DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 967 filers reported holding DANAHER CORPORATION in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $698,000 | +3.1% | 7,141 | -2.1% | 0.28% | 0.0% |
| Q4 2017 | $677,000 | +1.5% | 7,295 | -6.2% | 0.28% | +3.7% |
| Q3 2017 | $667,000 | +0.3% | 7,778 | -1.3% | 0.27% | -3.2% |
| Q2 2017 | $665,000 | -2.8% | 7,882 | -1.6% | 0.28% | -39.9% |
| Q1 2017 | $684,000 | +5.7% | 8,007 | -3.7% | 0.47% | +2.6% |
| Q4 2016 | $647,000 | -1.7% | 8,317 | -0.9% | 0.46% | +13.4% |
| Q3 2016 | $658,000 | -36.7% | 8,396 | -18.5% | 0.40% | -40.3% |
| Q2 2016 | $1,040,000 | -6.9% | 10,301 | -12.5% | 0.68% | -10.5% |
| Q1 2016 | $1,117,000 | +0.4% | 11,777 | -1.7% | 0.75% | +3.0% |
| Q4 2015 | $1,113,000 | +52.3% | 11,978 | +39.7% | 0.73% | +50.6% |
| Q3 2015 | $731,000 | -0.7% | 8,576 | -0.2% | 0.49% | +2.5% |
| Q2 2015 | $736,000 | -0.3% | 8,596 | -1.1% | 0.47% | +3.7% |
| Q1 2015 | $738,000 | -0.8% | 8,696 | +0.2% | 0.46% | -4.0% |
| Q4 2014 | $744,000 | +15.7% | 8,675 | +2.4% | 0.48% | +19.0% |
| Q3 2014 | $643,000 | +40.1% | 8,468 | +45.3% | 0.40% | +44.9% |
| Q2 2014 | $459,000 | +5.3% | 5,827 | +0.3% | 0.28% | 0.0% |
| Q1 2014 | $436,000 | -11.2% | 5,811 | -8.7% | 0.28% | -15.3% |
| Q4 2013 | $491,000 | -25.7% | 6,363 | -33.3% | 0.33% | -33.2% |
| Q3 2013 | $661,000 | +0.3% | 9,537 | -8.4% | 0.49% | -5.6% |
| Q2 2013 | $659,000 | – | 10,406 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |